-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Benitec Biopharma Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2019 to Q3 2024.
- Benitec Biopharma Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$5.06M, a 15% increase year-over-year.
- Benitec Biopharma Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$20.9M, a 2.12% decline year-over-year.
- Benitec Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$21.8M, a 11.2% decline from 2023.
- Benitec Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$19.6M, a 7.44% decline from 2022.
- Benitec Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$18.2M, a 31.2% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)